Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
Posted inAdvertising and Marketing Biogen Inc Drugs (Pharmaceuticals) Elderly Food and Drug Administration House Committee on Energy and Commerce House Committee on Oversight and Government Reform Labeling and Labels (Product) Maloney, Carolyn B Pallone, Frank Jr

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
Will This Device Protect Athletes’ Brains, or Only Make Them Think It Does?
Posted inBauer Nike Hockey Inc Brain Chronic Traumatic Encephalopathy Concussions Defense Department Food and Drug Administration Football Inventions and Patents National Football League Premier Lacrosse League Protective Clothing and Gear

Will This Device Protect Athletes’ Brains, or Only Make Them Think It Does?

More and more pro and college athletes are trying on the Q-Collar as they search for something, anything, that might keep their brains safe. But does it work?
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Posted inDrug Resistance (Microbial) Drugs (Pharmaceuticals) Food and Drug Administration Hospitals Infections Law and Legislation Politics and Government Regulation and Deregulation of Industry United States Politics and Government

Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?

Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.